163 related articles for article (PubMed ID: 37348925)
21. Monoclonal gammopathy of ocular significance (MGOS) - a short survey of corneal manifestations and treatment outcomes.
Garderet L; Al Hariri M; Wasielica-Poslednik J; Munder M; Kormányos K; Pena C; Gozzetti A; Zhou X; Waszczuk-Gajda A; Rosinol L; Mikala G; Krzystanski M; Lisch W; Vesole D; Szentmáry N; Jurczyszyn A
Leuk Lymphoma; 2022 Apr; 63(4):984-990. PubMed ID: 34823428
[TBL] [Abstract][Full Text] [Related]
22. Crystalglobulinemia manifested as acute renal failure and thrombotic vasculopathy.
Gómez-Lechón Quirós L; Acosta De La Vega ME; Compán Fernández O; Pastor Navarro S; Montilla Morales C; Moyano Bueno D; Martín Centellas J; Santos-Briz Terrón A; Hidalgo Calleja C
Rheumatol Int; 2020 Aug; 40(8):1327-1332. PubMed ID: 32533290
[TBL] [Abstract][Full Text] [Related]
23. [Monoclonal gammopathy of undetermined significance and multiple myeloma].
Schmalzing M; Tony HP; Knop S
Z Rheumatol; 2017 Oct; 76(Suppl 2):33-37. PubMed ID: 29330758
[TBL] [Abstract][Full Text] [Related]
24. Monoclonal gammopathy of uncertain significance.
Alejo E; Puertas B; Mateos MV
Med Clin (Barc); 2023 Sep; 161(5):217-224. PubMed ID: 37330390
[TBL] [Abstract][Full Text] [Related]
25. [Monoclonal gammopathy and osteolytic lesions as the initial manifestation of a metastatic hypernephroma].
Castillo Jimeno JM; Illarramendi Mañas JJ; Ruiz Rubio JL; Santiago González A; Sebastián Borruel JL
Arch Esp Urol; 1991 Nov; 44(9):1110-2. PubMed ID: 1807217
[TBL] [Abstract][Full Text] [Related]
26. Testing and management for monoclonal gammopathy of uncertain significance and myeloma patients presenting with osteoporosis and fragility fractures.
Nador G; Ramasamy K; Panitsas F; Pratt G; Sadler R; Javaid MK
Rheumatology (Oxford); 2019 Jul; 58(7):1142-1153. PubMed ID: 31225884
[TBL] [Abstract][Full Text] [Related]
27. Acquired von willebrand syndrome secondary to monoclonal gammopathy of undetermined significance: long-term remission after treatment with bortezomib.
Saldanha A; Veiga ME; Okazaki E; Rothschild C; Martinez G; Rocha V; Orsi FA; Villaca P
J Thromb Thrombolysis; 2023 May; 55(4):770-774. PubMed ID: 37000318
[TBL] [Abstract][Full Text] [Related]
28. Myeloma-like Castleman disease with plasmacytosis and monoclonal gammopathy.
Hsieh CY; Hsu CM; Chang KC; Hsiao HH
Kaohsiung J Med Sci; 2022 Oct; 38(10):1022-1023. PubMed ID: 35880609
[No Abstract] [Full Text] [Related]
29. [Cerebrospinal fluid proteins in 3 cases of polyneuritis complicating plasma cell dyscrasias].
Merelli E; Sola P; Galassi G; Gibertoni M; Colombo A; Shoenhuber R
Riv Neurobiol; 1984; 30(2-3):240-8. PubMed ID: 6544480
[No Abstract] [Full Text] [Related]
30. Bone-marrow immunophenotypic analysis allows the identification of high risk of progression and immune condition-related monoclonal gammopathy of undetermined significance.
Jerez A; Ortuño FJ; Osma Mdel M; Español I; González AD; Roldán V; de Arriba F; Vicente V
Ann Med; 2009; 41(7):547-58. PubMed ID: 19634064
[TBL] [Abstract][Full Text] [Related]
31. Diffuse plane xanthoma developing in association with prior monoclonal gammopathy.
Falk L; Dyall-Smith D; Stolz W; Coras-Stepanek B
BMJ Case Rep; 2019 Feb; 12(2):. PubMed ID: 30765451
[No Abstract] [Full Text] [Related]
32. [Nephropathies in the course of plasma cell disorders].
Hanicki Z
Przegl Lek; 1995; 52(3):97-9. PubMed ID: 7644685
[No Abstract] [Full Text] [Related]
33. Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.
Rajkumar SV; Mesa RA; Fonseca R; Schroeder G; Plevak MF; Dispenzieri A; Lacy MQ; Lust JA; Witzig TE; Gertz MA; Kyle RA; Russell SJ; Greipp PR
Clin Cancer Res; 2002 Jul; 8(7):2210-6. PubMed ID: 12114422
[TBL] [Abstract][Full Text] [Related]
34. Hypercoagulability in multiple myeloma and its precursor state, monoclonal gammopathy of undetermined significance.
Kristinsson SY; Björkholm M; Schulman S; Landgren O
Semin Hematol; 2011 Jan; 48(1):46-54. PubMed ID: 21232658
[TBL] [Abstract][Full Text] [Related]
35. The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma.
Mikulasova A; Wardell CP; Murison A; Boyle EM; Jackson GH; Smetana J; Kufova Z; Pour L; Sandecka V; Almasi M; Vsianska P; Gregora E; Kuglik P; Hajek R; Davies FE; Morgan GJ; Walker BA
Haematologica; 2017 Sep; 102(9):1617-1625. PubMed ID: 28550183
[TBL] [Abstract][Full Text] [Related]
36. Secondary monoclonal gammopathy of undetermined significance after allogeneic stem cell transplantation in multiple myeloma.
Schmitz MF; Otten HG; Franssen LE; van Dorp S; Strooisma T; Lokhorst HM; van de Donk NW
Haematologica; 2014 Dec; 99(12):1846-53. PubMed ID: 25193963
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal gammopathy of undetermined significance: a new proposal of workup.
Mangiacavalli S; Cocito F; Pochintesta L; Pascutto C; Ferretti V; Varettoni M; Zappasodi P; Pompa A; Landini B; Cazzola M; Corso A
Eur J Haematol; 2013 Oct; 91(4):356-60. PubMed ID: 23859528
[TBL] [Abstract][Full Text] [Related]
38. Review of diffusion-weighted imaging and dynamic contrast-enhanced MRI for multiple myeloma and its precursors (monoclonal gammopathy of undetermined significance and smouldering myeloma).
Van Den Berghe T; Verstraete KL; Lecouvet FE; Lejoly M; Dutoit J
Skeletal Radiol; 2022 Jan; 51(1):101-122. PubMed ID: 34523007
[TBL] [Abstract][Full Text] [Related]
39. Importance of quantitative histology of bone changes in monoclonal gammopathy.
Bataille R; Chappard D; Alexandre C; Dessauw P; Sany J
Br J Cancer; 1986 Jun; 53(6):805-10. PubMed ID: 3718833
[TBL] [Abstract][Full Text] [Related]
40. Differences in the distribution of cytogenetic subtypes between multiple myeloma patients with and without a family history of monoclonal gammopathy and multiple myeloma.
Greenberg AJ; Cousin M; Kumar S; Ketterling RP; Knudson RA; Larson D; Colby C; Scott C; Vachon CM; Vincent Rajkumar S
Eur J Haematol; 2013 Sep; 91(3):193-195. PubMed ID: 23647020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
